Engagements

Global pricing assessment and forecast

CRA forecasted potential price ranges and access based on future competitive and product scenarios in order to help a client decide whether to co-develop and co-commercialize an early stage asset.

Related capabilities

Life Sciences
Pricing & Market Access

Life Sciences
CRA Insights

The evolving vaccine landscape: Insights from the 6th ESCMID Conference on Vaccines

The conference brought together the vaccine community and stakeholders, including industry representatives, clinicians, regulators, policymakers, academics,...
Life Sciences
CRA Insights

TrumpRx: Enabling direct-to-patient care?

As of December 11, 2025, a variety of manufacturers have reached agreements or stated their intent to offer discounted prices for some of their medications...

Explore our thinking

Global pricing assessment and forecast

Related insights

The evolving vaccine landscape: Insights from the 6th ESCMID Conference on Vaccines

TrumpRx: Enabling direct-to-patient care?